HUTCHMED (China) Limited (HK:0013) has released an update.
HUTCHMED (China) Limited has announced its total number of voting rights, revealing an issued share capital composed of over 871 million ordinary shares, each with one vote and none held in treasury. This information is critical for shareholders to understand their notification requirements under the Financial Conduct Authority’s rules. Additionally, the company highlights its commitment to developing targeted therapies and immunotherapies for cancer and immunological diseases, with a significant global presence and three marketed medicines.
For further insights into HK:0013 stock, check out TipRanks’ Stock Analysis page.
